Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Efficacy Study
Official Title:	Endothelial Dysfunction Reversibility in Patients With Peripheral Arterial Disease

Ages Eligible for Study:	18 Years to 70 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Please refer to this study by its ClinicalTrials.gov identifier: NCT00487617

Contact: Olivier Rouyer, MD

33.3.88.11.61.22

olivier.rouyer@chru-strasbourg.fr

France
Service de Physiologie et d'Explorations Fonctionnelles	Recruiting
Strasbourg, France, 67091
Contact: Olivier Rouyer, MD     33.3.88.11.61.22     olivier.rouyer@chru-strasbourg.fr
Principal Investigator: Olivier Rouyer, MD
Sub-Investigator: Bernard Geny, MD
Service de Chirurgie Vasculaire	Recruiting
Strasbourg, France, 67091
Contact: Fabien Thaveau, MD     33.3.88.11.60.68     fabien.thaveau@chru-strasbourg.fr
Principal Investigator: Fabien Thaveau, MD
Sub-Investigator: Nabil Chakfe, MD
Sub-Investigator: Jean-Georges Kretz, MD

Study Director:

Olivier Rouyer, MD

Hôpitaux Universitaires de Strasbourg

Responsible Party:	University Hospital, Strasbourg, France ( Emmanuel LAVOUE, Directeur Adjoint de la DRCI )
Study ID Numbers:	3801
Study First Received:	June 15, 2007
Last Updated:	February 29, 2008
ClinicalTrials.gov Identifier:	NCT00487617
Health Authority:	France: Ministry of Health

Keywords provided by University Hospital, Strasbourg, France:
Study placed in the following topic categories:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on January 16, 2009